FDA Confirms Nestlé Addressing All Complaints on Recalled Infant Formula Products
The Food and Drug Administration (FDA) announced on Tuesday, March 3, 2026, that all concerns raised by parents and caregivers regarding the recalled Nan Optipro and Nankid Optipro products are being actively attended to by Nestlé Philippines Inc. In an official statement, the agency detailed that complaints received directly by the FDA have been referred to the company for handling.
Complaint Resolution and Monitoring Efforts
According to the FDA, Nestlé has reported that a majority of complaints received directly by the company have already been addressed. The FDA emphasized that continuous monitoring and follow-up are ongoing to ensure all issues are resolved promptly. The agency remains open to receiving additional reports through its eSumbong platform, accessible via the official FDA website, or via email at ereport@fda.gov.ph.
Parents and caregivers are strongly encouraged to stay attentive to official FDA advisories and report any concerns immediately, the FDA stated, highlighting the importance of public vigilance in such matters.
Recall Statistics and Product Destruction
Regarding the actual recall process, the FDA revealed that over 330,000 units of Nan Optipro and Nankid Optipro have been successfully retrieved by Nestlé. Specifically, a total of 330,004 units from 39 batches of these infant formula products have been recalled.
The FDA confirmed that 100% of all segregated recalled products are now under the control of Nestlé Philippines. Of this total, 199,414 units have been scheduled for destruction. We will take part in the scheduled destruction of the recalled products to ensure proper compliance with recall procedures, the FDA assured, underscoring its commitment to regulatory oversight.
Background on the Recall
Last January, Nestlé Philippines initiated the recall of specific batches of Nan Optipro and Nankid Optipro infant formula products. This action was taken following the detection of very low levels of cereulide, a toxin produced by the microorganism Bacillus cereus, in the arachidonic acid-rich (ARA) oil supplied to the company. The recall aims to mitigate any potential health risks associated with these contaminated batches.
The FDA continues to work closely with Nestlé to monitor the situation and ensure all safety protocols are followed, providing updates as necessary to protect public health.
